Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Senhwa Biosciences Highlights Breakthroughs in Dual First-in-Class Drug Programs at Annual Shareholders' Meeting Today 2025-06-25 19:00
EDAN Establishes Mexico Subsidiary to Strengthen Presence in the Americas 2025-06-25 18:07
QBIOTICS REPORTS 80% OBJECTIVE RESPONSE RATE IN INJECTED TUMOURS IN STAGE 1 OF PHASE IIA CLINICAL TRIAL OF TIGILANOL TIGLATE FOR SOFT TISSUE SARCOMA 2025-06-25 18:05
IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy of Neurology (EAN) 2025-06-23 10:01
Harbour BioMed Enters Global Strategic Collaboration with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers 2025-06-23 08:03
Dizal Completes Enrollment for its Phase III Pivotal Study of Sunvozertinib vs. Platinum Doublet in Treatment Naïve NSCLC Patients with EGFR Exon20 Insertional Mutations 2025-06-19 18:08
Simcere Zaiming Announces First Patient Dosed in the US in a Phase 1 Trial of Trispecific Antibody SIM0500 in Patients with Relapsed/Refractory Multiple Myeloma 2025-06-19 08:37
Medison Expands Global Leadership Team with Chief Business Officer and Chief Legal & Compliance Officer 2025-06-18 22:36
WuXi AppTec Earns SBTi Validation for Near-Term Emissions Reduction Targets 2025-06-18 08:00
Makera's Desktop CNC Revolution: How One Company's Innovation Is Transforming Medical Research 2025-06-17 21:38
HanchorBio Presents Promising Data on HCB101 Checkpoint Inhibitor Immunotherapy at ASCO 2025-06-17 18:00
Clover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates 2025-06-17 12:48
HELP Therapeutics and China Resources Sanjiu Announce Strategic Partnership to Co-Develop and Commercialize HiCM-188 for Advanced Heart Failure in Mainland China 2025-06-16 22:40
Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology 2025-06-16 21:03
WuXi AppTec Recognized by Extel 2025 Asia Executive Team Rankings with Top Honors 2025-06-16 20:00
PATHOLOGICAL COMPLETE RESPONSE RECORDED IN PATIENT FROM ACCENT CANCER TRIAL 2025-06-16 19:00
NUZ-001 Shows Promise in Zebrafish Model of Huntington's Disease 2025-06-16 19:00
Samsung Biologics launches drug screening services, Samsung Organoids 2025-06-16 07:30
Celltrion announces U.S. FDA approval of additional presentation of STEQEYMA® (ustekinumab-stba), expanding dosing options for pediatric patients 2025-06-16 07:30
Neurophet Participates in BIO USA 2025: To showcase Brain Imaging Analysis Solutions Including 'Neurophet AQUA AD' 2025-06-13 21:00
1 17 18 19 20 21 262